Weight gain is a common issue among aging men, with more than a third of men being overweight. While diet and exercise are often recommended to address weight gain, these approaches may not always produce the desired outcomes due to several factors. Consequently, men may experience increased frustration, embarrassment, or may abandon their weight loss efforts altogether.
The gradual increase in weight may be caused by several factors such as age, lifestyle changes, and a potentially slower metabolism. With age, our metabolism naturally slows down, making it challenging to convert food into energy, leading to fat accumulation. We understand the frustration associated with this issue, and at Tri-State Men's Health, we are committed to providing solutions for men who have tried various approaches to address their weight concerns.
Men with these symptoms could benefit from an evaluation:
Our licensed medical providers will establish whether GLP-1 treatment is right for you and help you regain the confidence and body you once had.
Our expert medical staff will assess your eligibility for GLP-1 by measuring your Body Mass Index (BMI) at the beginning. If you are found to be a suitable candidate for GLP-1, the medical professionals at Tri-State Men's Health will design a customized treatment plan that not only focuses on weight loss but also aims to help you regain lost energy and vitality.
Our expert medical team at Tri-State Men's Health will closely monitor your progress during GLP-1 treatment to promptly identify and manage any potential side effects. Although some men may experience temporary side effects such as nausea, vomiting, diarrhea, abdominal pain, constipation, heartburn, and burping, these symptoms typically resolve within the first month. If you or any of your family members have a history of Medullary Thyroid Carcinoma (MTC) or Endocrine Neoplasia Syndrome type 2 (MEN2), it is advisable not to take GLP-1.
It is worth noting that the average weight loss achieved in three 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, coupled with a reduced-calorie diet and increased physical activity, was used as a basis for our treatment approach.